RSL1D1 and colorectal carcinoma: These findings suggested that RSL1D1 inhibited the deacetylation of RAN by competitively binding with Sirt7, which reduced the accumulation of nuclear STAT3 and then promoted the proliferation and invasion of CRC cells by suppressing autophagy.